Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Location status: Recruiting
Location contact
Megan Melland-Smith, MD
CONTACT
Michael Rosen, MD
SUB_INVESTIGATOR
Nancy Ly, MD
CONTACT
Steven Schwulst, MD
SUB_INVESTIGATOR
NCT Number: NCT07422584
This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure.
The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Chicago, Illinois, 60611, United States
Location status: Recruiting
Megan Melland-Smith, MD
CONTACT
Michael Rosen, MD
SUB_INVESTIGATOR
Nancy Ly, MD
CONTACT
Steven Schwulst, MD
SUB_INVESTIGATOR
Major abdominal wall reconstruction (AWR) for large ventral hernias is among the most physiologically demanding procedures performed in general surgery. These patients often have a history of multiple prior abdominal operations, chronically altered abdominal wall mechanics and significant loss of domain. Reduction of visceral contents and abdominal wall reconstruction frequently require high-tension closure, resulting in an abrupt increase in intra-abdominal pressure (IAP) that impairs diaphragmatic excursion, reduces splanchnic perfusion, causes renal venous congestion and induces global physiologic stress. Consequently, these patients face a high risk of postoperative complications including respiratory failure, renal dysfunction, and prolonged intensive care unit (ICU) stays.
A critical gap in AWR research is the lack of characterization of the biologic inflammatory and cytokine responses associated with high-tension abdominal wall closure. This gap stands in contrast to robust evidence from the trauma and critical care literature demonstrating that cytokine activation correlates with injury severity and contributes to organ dysfunction and postoperative morbidity.
Defining the inflammatory and cytokine signaling pathways activated during high-tension closure would provide a framework to inform operative planning and perioperative management, particularly in patients with significant comorbidities who may be less tolerant to postoperative physiologic stress. These insights would enable validation of current techniques and establish the foundation for future interventional trials targeting inflammatory pathways to improve postoperative outcomes. The Digestive Health Institute at Northwestern University is uniquely positioned to support this translational research, bridging surgical physiology, inflammation, and patient outcomes.
The investigators hypothesize that:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Surgical Participants
Exclusion criteria
There are no interventions in this observational study.
Time frame: Baseline through postoperative day 5
Blood and peritoneal fluid will be collected at baseline (intra-operative), immediately following fascial closure and on postoperative days 1, 3, and 5. Serum cytokine concentrations of GM-CSF, IFN-gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha (inflammatory); IL-4 and IL-10 (anti-inflammatory) will be measured via multiplex immunoassays (Luminex). Cytokine area under the curve will also be calculated to allow analysis of total cytokine exposure over time.
Time frame: Baseline through postoperative day 5
Peripheral blood mononuclear cells (PBMCs) and peritoneal macrophages will be isolated at baseline, immediately following fascial closure and on postoperative days 1, 3, and 5. Bulk RNA sequencing will be performed. Differentially expressed genes will be determined and KEGG and GO pathway analyses performed.
Time frame: Baseline through postoperative day 5
Intra-abdominal pressure (IAP) will be assessed using bladder pressure measurements, along with plateau pressure and abdominal perfusion pressure (APP) - calculated as mean arterial pressure (MAP) minus IAP. Measurements will be obtained at baseline, POD1, POD3 and POD5. Measures will include peak IAP, and duration of intra-abdominal hypertension (IAH), defined as IAP >12mmHg. Peak serum cytokine levels will be correlated with peak IAP using Spearman correlation and multivariable linear regression.
Time frame: From surgery through hospital discharge (up to 30 days)
Respiratory compromise defined as failure to wean from mechanical ventilation or development of postoperative pneumonia.
Time frame: From surgery through hospital discharge (up to 30 days)
Acute kidney injury defined as increase in serum creatinine to >1.5 times baseline with urine output <0.5 mL/kg/hr for 6 hours.
Time frame: From surgery through hospital discharge (up to 30 days)
Requirement for vasopressor support postoperatively.
Time frame: From surgery through hospital discharge (up to 30 days)
Development of postoperative ileus as documented in the medical record.
Time frame: From surgery through hospital discharge (up to 30 days)
Development of surgical site infection or wound dehiscence
Time frame: From surgery through hospital discharge (up to 30 days)
Number of days in the intensive care unit following surgery.
Time frame: From surgery through hospital discharge (up to 30 days)
Total number of days hospitalized following surgery.
Contact information is provided by the study sponsor or research team.
Megan Melland-Smith, MD
CONTACT
Nancy Ly, MD
CONTACT
Northwestern University
Other
Pilot Study of Systemic Inflammatory and Transcriptomic Responses in Patients Undergoing Open Retromuscular Ventral Hernia Repair
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01953302
Disease Attributes, Hematoma
Varaždin, Croatia
View Trial Details